Specialities

Specialities

Acne
Aesthetic Dermatology
Allergic Conditions
Alopecia Areata
Autoimmune Diseases
Dermatitis
Dermato-oncology
Dermatological Disorders
Dermatological Surgery
Epidermolysis Bullosa
Hidradenitis Suppurativa
Infectious Diseases
Paediatric Dermatology
Pigmentation Disorders
Prurigo Nodularis
Psoriasis
Rare Diseases
Rosacea
Scars
Teledermatology
Urticaria
Search

Trending Topic

roflilumast foam
5 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

What roflumilast 0.3% foam brings to your psoriasis clinical toolkit

Jennifer Soung

The FDA recently approved roflumilast 0.3% foam for the treatment of plaque psoriasis of the scalp and body in both adolescents and adults. To better understand how this newly approved therapy fits into clinical practice, what the data show and which patients are likely to benefit, we spoke with Dr Jennifer Soung (Harbor University of California, Los Angeles and Southern California Dermatology, Santa Ana, CA, USA), a key investigator on the phase 3 ARRECTOR trial.

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Society & Congress Partners

touchDERMATOLOGY is proud to partner with these leading medical societies and congresses from around the world to bring you news and insight from virtual and live events.

New Partners COMING SOON.

EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI)

XIV International Congress of Dermatology 2025

Medics4RareDiseases

Urticaria Centers of Reference and Excellence (UCARE)

touchDERMATOLOGY touchDERMATOLOGY

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

  • Save your progress for video
  • Keep track of your CME credits
  • Add personalised learning notes
  • Receive updates from course leaders and faculty
  • Be the first to hear about new and exciting interactive learning opportunities

Latest articles videos and clinical updates - straight to your inbox

Close Popup